Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
August 17, 2021
COVID-19 Outcomes Among Users of CD20 Inhibitors for Immune-Mediated Diseases: A Comparative Cohort Study
Naomi J Patel, Kristin M D'Silva, Tiffany Y-T Hsu, et al.
ACR Open Rheumatology
|
December 10, 2021
Coronavirus Disease 2019 Outcomes Among Recipients of Anti-CD20 Monoclonal Antibodies for Immune-Mediated Diseases: A Comparative Cohort Study
Naomi J Patel, Kristin M D'Silva, Tiffany Y-T Hsu, et al.
Annals of the Rheumatic Diseases
|
August 9, 2022
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave
Yumeko Kawano, Naomi J Patel, Xiaosong Wang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 29, 2022
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron
Yumeko Kawano, Naomi J Patel, Xiaosong Wang, et al.
Arthritis Care & Research
|
March 21, 2022
Assessing the Severity of COVID-19 Lung Injury in Rheumatic Diseases Versus the General Population Using Deep Learning-Derived Chest Radiograph Scores
Naomi J Patel, Kristin M D'Silva, Matthew D Li, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 16, 2022
DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study
Michael Di Iorio, Claire E Cook, Kathleen M M Vanni, et al.
Seminars in Arthritis and Rheumatism
|
May 26, 2022
DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study
Michael Di Iorio, Claire E Cook, Kathleen M M Vanni, et al.
The Lancet. Rheumatology
|
June 7, 2021
Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study
Tiffany Y-T Hsu, Kristin M D'Silva, Naomi J Patel, et al.
Cell Reports
|
December 3, 2014
The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressor
Kristen L Karlin, Gourish Mondal, Jessica K Hartman, et al.
Nature
|
September 3, 2015
The spliceosome is a therapeutic vulnerability in MYC-driven cancer
Tiffany Y-T Hsu, Lukas M Simon, Nicholas J Neill, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Medrxiv : the Preprint Server for Health Sciences
|
August 17, 2021
COVID-19 Outcomes Among Users of CD20 Inhibitors for Immune-Mediated Diseases: A Comparative Cohort Study
Naomi J Patel, Kristin M D'Silva, Tiffany Y-T Hsu, et al.
ACR Open Rheumatology
|
December 10, 2021
Coronavirus Disease 2019 Outcomes Among Recipients of Anti-CD20 Monoclonal Antibodies for Immune-Mediated Diseases: A Comparative Cohort Study
Naomi J Patel, Kristin M D'Silva, Tiffany Y-T Hsu, et al.
Annals of the Rheumatic Diseases
|
August 9, 2022
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave
Yumeko Kawano, Naomi J Patel, Xiaosong Wang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 29, 2022
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron
Yumeko Kawano, Naomi J Patel, Xiaosong Wang, et al.
Arthritis Care & Research
|
March 21, 2022
Assessing the Severity of COVID-19 Lung Injury in Rheumatic Diseases Versus the General Population Using Deep Learning-Derived Chest Radiograph Scores
Naomi J Patel, Kristin M D'Silva, Matthew D Li, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 16, 2022
DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study
Michael Di Iorio, Claire E Cook, Kathleen M M Vanni, et al.
Seminars in Arthritis and Rheumatism
|
May 26, 2022
DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study
Michael Di Iorio, Claire E Cook, Kathleen M M Vanni, et al.
The Lancet. Rheumatology
|
June 7, 2021
Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study
Tiffany Y-T Hsu, Kristin M D'Silva, Naomi J Patel, et al.
Cell Reports
|
December 3, 2014
The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressor
Kristen L Karlin, Gourish Mondal, Jessica K Hartman, et al.
Nature
|
September 3, 2015
The spliceosome is a therapeutic vulnerability in MYC-driven cancer
Tiffany Y-T Hsu, Lukas M Simon, Nicholas J Neill, et al.
Page
of 3